Evoke Pharma Inc (EVOK.OQ)
EVOK.OQ on NASDAQ Stock Exchange Capital Market
2.39USD
3:41pm BST
2.39USD
3:41pm BST
Change (% chg)
$0.05 (+2.14%)
$0.05 (+2.14%)
Prev Close
$2.34
$2.34
Open
$2.33
$2.33
Day's High
$2.39
$2.39
Day's Low
$2.33
$2.33
Volume
110
110
Avg. Vol
15,566
15,566
52-wk High
$4.09
$4.09
52-wk Low
$1.86
$1.86
Consensus Recommendations
Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
---|---|---|---|
Outperform | -0.16 | December | 25 Apr 2018 |
Analyst Recommendations and Revisions
1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
---|---|---|---|---|
(1) BUY | 0 | 0 | 0 | 0 |
(2) OUTPERFORM | 5 | 5 | 5 | 5 |
(3) HOLD | 0 | 0 | 0 | 0 |
(4) UNDERPERFORM | 0 | 0 | 0 | 0 |
(5) SELL | 0 | 0 | 0 | 0 |
No Opinion | 0 | 0 | 0 | 0 |
Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
# of Estimates | Mean | High | Low | 1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Sep-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
Year Ending Dec-18 | 3 | 0.00 | 0.00 | 0.00 | 18.95 |
Year Ending Dec-19 | 5 | 32.03 | 113.20 | 0.00 | 64.37 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | 4 | -0.16 | -0.09 | -0.25 | -0.20 |
Quarter Ending Sep-18 | 4 | -0.11 | -0.05 | -0.18 | -0.18 |
Year Ending Dec-18 | 4 | -0.56 | -0.40 | -0.84 | -0.13 |
Year Ending Dec-19 | 5 | -0.16 | 1.85 | -0.97 | 0.55 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
---|---|---|---|---|
SALES (in millions) | ||||
Quarter Ending Dec-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Sep-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Jun-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Mar-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Dec-16 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings (per share) | ||||
Quarter Ending Dec-17 | -0.23 | -0.02 | 0.21 | -91.38 |
Quarter Ending Sep-17 | -0.20 | -0.34 | 0.14 | -68.32 |
Quarter Ending Jun-17 | -0.15 | -0.11 | 0.04 | -26.67 |
Quarter Ending Mar-17 | -0.16 | -0.15 | 0.01 | -7.69 |
Quarter Ending Dec-16 | -0.19 | -0.12 | 0.07 | -38.14 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Sep-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Year Ending Dec-18 | 0.00 | 0.00 | 0.00 | 18.95 | 18.95 |
Year Ending Dec-19 | 32.03 | 32.03 | 35.33 | 55.75 | 64.37 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | -0.16 | -0.16 | -0.16 | -0.13 | -0.20 |
Quarter Ending Sep-18 | -0.11 | -0.11 | -0.12 | -0.12 | -0.18 |
Year Ending Dec-18 | -0.56 | -0.56 | -0.57 | -0.21 | -0.13 |
Year Ending Dec-19 | -0.16 | -0.16 | -0.11 | 0.24 | 0.55 |
Estimates Revisions Summary
Last Week | Last 4 Weeks | |||
---|---|---|---|---|
Number Of Revisions: | Up | Down | Up | Down |
Revenue | ||||
Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings | ||||
Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
Quarter Ending Sep-18 | 0 | 0 | 1 | 0 |
Year Ending Dec-18 | 0 | 0 | 1 | 0 |
Year Ending Dec-19 | 0 | 0 | 0 | 0 |
- BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments
- BRIEF-Evoke Pharma Q4 Loss Per Share $0.02
- BRIEF-FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application
- BRIEF-Evoke Pharma Announces Discovery Of Sex-Based Pharmacokinetic Differences For Gimoti
- BRIEF-Evoke Pharma reports Q3 loss per share $0.34